BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Carb-X - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Carb-X
X-ORIGINAL-URL:https://carb-x.org
X-WR-CALDESC:Events for Carb-X
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Berlin
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190709T110000
DTEND;TZID=America/New_York:20190709T123000
DTSTAMP:20260427T152327
CREATED:20190528T160533Z
LAST-MODIFIED:20190620T144353Z
UID:3060-1562670000-1562675400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Infection models for antimicrobial R&D: Intracellular models
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, Françoise van Bambeke\, Research Director Cellular and Molecular Pharmacology\, Louvain Drug Research Institute\, Catholic University of Louvain (FR)\, will talk about intracellular activity of antibiotics. Topics discussed will include: \n\nThe role of intracellular survival in chronic infections and its contribution to poor response to antibiotics\nIn vitro models to study intracellular activity of antibiotics\nCellular pharmacokinetic (PK) parameters predictive of intracellular potency for antibiotics\nCellular pharmacodynamics (PD) parameters predictive of intracellular efficacy for antibiotics\n\nThe presentation will be followed by a Q&A session \nSpeakers:\nFrançoise van Bambeke\, Research Director Cellular and Molecular Pharmacology\, Louvain Drug Research Institute\, Catholic University of Louvain (FR) \nModerator:\nLaura Piddock\, Director of Scientific Affairs\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-infection-models-for-antimicrobial-rd-intracellular-models/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190626T103000
DTEND;TZID=America/New_York:20190626T113000
DTSTAMP:20260427T152327
CREATED:20190620T134850Z
LAST-MODIFIED:20190620T134850Z
UID:3143-1561545000-1561548600@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE - Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
DESCRIPTION:In this webinar\, Dr Manica Balasegaram\, GARDP’s Executive Director will highlight GARDP’s role in accelerating the implementation of WHO’s Global Action Plan\, and share GARDP’s updated strategy. Following his presentation\, you will have the opportunity to ask questions in a Q&A session moderated by Jennifer Katz\, GARDP’s Director of External Affairs. \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-find-out-how-gardp-is-redoubling-its-efforts-to-accelerate-the-development-and-delivery-of-new-and-improved-antibiotics/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190611T170000
DTEND;TZID=Europe/Berlin:20190611T183000
DTSTAMP:20260427T152327
CREATED:20190528T160224Z
LAST-MODIFIED:20190528T160702Z
UID:3058-1560272400-1560277800@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar\, William J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy\, will introduce experimental design of animal models for antimicrobial research. He will discuss questions such as 1) Where to start and what model to use? 2) Are animal models of bacterial infection reflective of the clinical condition? 3) Are in vivo animal model results predictive of clinical efficacy? The presentation will be followed by a Q&A session moderated by Peter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec. \nSpeakers:\nWilliam J. Weiss\, Director\, PreClinical Services\, University of North Texas System College of Pharmacy \nModerator:\nPeter Warn\, Senior Vice President\, Anti-infective Discovery\, Evotec \nRegister here for this live webinar.
URL:https://carb-x.org/event/live-webinar-gardp-revive-models-for-antimicrobial-rd-development-and-use-of-in-vivo-models-for-infectious-disease-research/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190611T100000
DTEND;TZID=America/New_York:20190611T110000
DTSTAMP:20260427T152327
CREATED:20190517T135538Z
LAST-MODIFIED:20190528T155538Z
UID:3015-1560247200-1560250800@carb-x.org
SUMMARY:Live Webinar: Funding Opportunities for Antimicrobial Drug Development from the Cystic Fibrosis Foundation
DESCRIPTION:Interested in new funding opportunities for infection drug development?\nThe Cystic Fibrosis Foundation (CFF) has teamed up with CARB-X to host a live webinar on June 11\, from 10:00am – 11:00am ET\, to introduce their new Infection Research Initiative. \nDuring the webinar\, Dr. Ann Field\, Senior Director of Drug Discovery and Development at the Cystic Fibrosis Foundation\, will discuss potential funding opportunities for therapeutic development of anti-infectives in key organisms of interest for CF infections.  The presentation will be followed by an interactive Q&A session. \nWebinar Summary\nLearn about funding opportunities for infection drug development through the Cystic Fibrosis Foundation. This webinar will include: \n\nOverview of the CF Foundation and the recently announced Infection Research Initiative\nCF Foundation interest in supporting therapeutic development for anti-infectives in key organisms of interest for CF infections\nTherapeutic Development Award Process and collaboration opportunities\n\nTo join this webinar\, please register here. \nIf you have questions or comments\, please let us know. Feel free to email your questions or comments to Raj Shetty at dshetty@carbx.org before the webinar\, or save them for the live Q&A session following the presentation.  We look forward to hearing from you!
URL:https://carb-x.org/event/webinar-funding-opportunities-for-antimicrobial-drug-development-from-the-cystic-fibrosis-foundation/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Berlin:20190604T133000
DTEND;TZID=Europe/Berlin:20190604T150000
DTSTAMP:20260427T152327
CREATED:20190528T155449Z
LAST-MODIFIED:20190528T160555Z
UID:3052-1559655000-1559660400@carb-x.org
SUMMARY:Live Webinar: GARDP/REVIVE Mining Chemical Libraries for New Antibacterials - Session 2
DESCRIPTION:The overall goal of this series of webinars is to provide\, for the non-clinical developer\, an understanding of the risks of development for various kinds of antibacterial products. \nIn this webinar the recording of Carl Balibar’s presentation ‘Mining of chemical libraries for new antibacterials’ (original webinar on 21 May) will be followed by another live Q&A session with Carl. \nDespite the promise of target-based drug discovery ushered in by the genomics era\, no mechanistically novel rationally designed antibiotic has reached clinically utility to address the threat of multi-drug resistant bacterial pathogens. Phenotypic screening remains the primary source for new antibacterial compounds\, which mainly come from mining various chemical libraries. In this webinar\, Carl Balibar (Merck Research Laboratories) will discuss screen design\, target bias\, and hit-prioritization strategies to identify those entities with the greatest opportunity to be developed into the next new antibiotic. \nSpeakers:\nCarl Balibar\, Principal Scientist\, Merck Research Laboratories \nModerator:\nBenjamin Blasco\, Discovery Senior Project Manager\, GARDP \nRegister here for this live webinar.
URL:https://carb-x.org/event/mining-chemical-libraries-for-new-antibacterials-session-2/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20190321T083000
DTEND;TZID=America/New_York:20190321T140000
DTSTAMP:20260427T152327
CREATED:20190206T153806Z
LAST-MODIFIED:20190214T181749Z
UID:2332-1553157000-1553176800@carb-x.org
SUMMARY:Longitude Prize AMR Diagnostics Boston Workshop
DESCRIPTION:Speakers include Kevin Outterson\, CARB-X Executive Director. \nThe Longitude Prize is an international challenge prize competition that will ultimately select one point-of-care diagnostic product to receive a grand payout of 8 million British Pounds ($9.1 million). The winner will have proven that their test can significantly reduce misuse or overuse of antibiotics by creating an affordable\, accurate and rapid point-of-care diagnostic test. This test must be practical to use in the North America and Europe as well as low and middle-income countries (LMICs).  There are currently 83 teams competing for the Prize from 14 countries with a broad mix of entries from industry and academia. The Prize Rules can be found here. \nThe purpose of this workshop is to give existing competitors and those interested in competing more information regarding the Longitude Prize competition to help steer projects toward a winning configuration\, hear from experts on test needs in the United Kingdom (National Health Service) and lower and middle-income contexts (LMICs)\, and to provide a chance for test developers to engage with Longitude judges and the Nesta Team. \nThe Longitude Prize is hosted and managed by the Challenge Prize Centre at Nesta\, the Innovation Foundation based in London. \nPlease RSVP to Ruth Neale at ruth.neale@nesta.org.uk by Friday March 8\, 2019 if you plan to attend the workshop.
URL:https://carb-x.org/event/longitude-prize-boston-workshop/
LOCATION:Boston University School of Law\, 765 Commonwealth Avenue\, Boston\, MA\, 02215\, United States
END:VEVENT
END:VCALENDAR